Company intelligence / Profile preview
Benitec Biopharma Inc.
Hayward, California, United Statesbenitec.com ↗
- Ownership
- Public · BNTC
- Employees
- ~16
- Development stage
- Phase 1
01
Overview
The company’s lead program, BB‑301 for OPMD, has shown positive interim results in a Phase 1b/2a study. Treated subjects demonstrated clinically meaningful improvements in swallowing function, with some achieving clinically normal swallowing profiles. No effective drug therapies currently exist for OPMD; BB‑301 aims to address this unmet need by silencing the mutant PABPN1 gene and replacing it with a wild-type copy using AAV-mediated delivery. Additional dose escalation cohorts are ongoing.[6][8][9]
- Therapeutic areas
- NeurologyInfectious Diseases
- Modalities
- Gene therapy (AAV-based)DNA-directed RNA interference (ddRNAi)
- Industry
- Biotech
02
Drug pipeline
9 assets8 more assets in the full pipeline.
Request access →03
Partnerships
Biomics Biotechnologies (Hepatitis B program development partner)[3]
04
Financials
- Market cap
- $419.8M
- Total revenue
- $0
- Enterprise value
- $235.9M
Beyond the preview
Go deeper on Benitec Biopharma Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Benitec Biopharma Inc..